Vimarsana
Biggest News Aggregation in the World

Page 24 - Small Molecules News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Small Molecules. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Small Molecules Today - Breaking & Trending Today

Global Pharmaceutical Continuous Manufacturing Market Research Report 2023 Featuring Cambrex, SK Biotek, Corden Pharma, Patheon, Wuxi Biologics, and Fujifilm Diosynth Biotechnologies - Vimarsana News

Global Pharmaceutical Continuous Manufacturing Market Research Report 2023 Featuring Cambrex, SK Biotek, Corden Pharma, Patheon, Wuxi Biologics, and Fujifilm Diosynth Biotechnologies

/PRNewswire/ -- The "Global Pharmaceutical Continuous Manufacturing Market, Growth Opportunities" report has been added to ResearchAndMarkets.com's offering....

Lonza Completes Expansion of Conjugation Facility in Visp (CH) - Vimarsana News

Lonza Completes Expansion of Conjugation Facility in Visp (CH)

Lonza Group AG / Key word(s): Expansion Lonza Completes Expansion of Conjugation Facility in Visp (CH) 16.02.2023 / 14:00 CET/CEST Expansion adds development and manufacturing capacity for pre-clinical, clinical and commercial supply of bioconjugates and antibody-drug conjugates The Visp (CH) in...

Exploring two small molecules for the disintegration of alpha-synuclein fibrils - Vimarsana News

Exploring two small molecules for the disintegration of alpha-synuclein fibrils

In a recent study published in the Proceedings of the National Academy of Sciences, researchers assessed the capability of two small molecules of disintegrating alpha-synuclein fibrils.

Researchers discover small molecules that can lock SARS-CoV-2 spike proteins - Vimarsana News

Researchers discover small molecules that can lock SARS-CoV-2 spike proteins

The infamous spike proteins on the surface of SARS-CoV-2 help it bind to and enter human cells. Because of their important role in spreading infection, these spike proteins are one of the main targets for COVID-19 vaccines and treatments.

Lonza Prices CHF 300 Million Straight Bond with a 2.100% Coupon - Vimarsana News

Lonza Prices CHF 300 Million Straight Bond with a 2.100% Coupon

Lonza Group AG / Key word(s): Bond/Financing Lonza Prices CHF 300 Million Straight Bond with a 2.100% Coupon 08.02.2023 / 18:3...